Carolyn Coyne

Carolyn Coyne


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2019 in Science Immunology
Verified
Journal Article
Closed access
PDF file
SAStephanie E. Ander
Stephanie E. Ander
MDMichael Diamond
Michael Diamond
CCCarolyn Coyne
Carolyn Coyne
The placenta promotes tolerance of the semiallogeneic fetus while protecting against vertical transmission of infections.

1 May 2016 in Cell Host & Microbe
Verified
Journal Article
Closed access
ABAvraham Bayer
Avraham Bayer
NLNicholas J. Lennemann
Nicholas J. Lennemann
YOYingshi Ouyang
Yingshi Ouyang
JBJohn C. Bramley
John C. Bramley
SMStefanie Morosky
Stefanie Morosky
CCCarolyn Coyne
Carolyn Coyne

16 July 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
EDElizabeth Delorme-Axford
Elizabeth Delorme-Axford
RDRogier B. Donker
Rogier B. Donker
JMJean-Francois Mouillet
Jean-Francois Mouillet
TCTianjiao Chu
Tianjiao Chu
ABAvraham Bayer
Avraham Bayer
CCCarolyn Coyne
Carolyn Coyne
Placental trophoblasts form the interface between the fetal and maternal environments and serve to limit the maternal–fetal spread of viruses. Here we show that cultured primary human placental trophoblasts are highly resistant to infection by a number of viruses and, importantly, confer this resistance to nonplacental recipient cells by exosome-mediated delivery of specific microRNAs (miRNAs). We show that miRNA members of the chromosome 19 miRNA cluster, which are almost exclusively expressed in the human placenta, are packaged within trophoblast-derived exosomes and attenuate viral replication in recipient cells by the induction of autophagy. Together, our findings identify an unprecedented paracrine and/or systemic function of placental trophoblasts that uses exosome-mediated transfer of a unique set of placental-specific effector miRNAs to directly communicate with placental or maternal target cells and regulate their immunity to viral infections.

25 August 2021 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
CMChristina J. Megli
Christina J. Megli
CCCarolyn Coyne
Carolyn Coyne

1 May 2017 in Cell Host & Microbe
Verified
Journal Article
Closed access
NANitin Arora
Nitin Arora
YSYoel Sadovsky
Yoel Sadovsky
TDTerence S. Dermody
Terence S. Dermody
CCCarolyn Coyne
Carolyn Coyne

10 March 2011 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
Amitava MukherjeeAmitava Mukherjee
Amitava Mukherjee
SMStefanie A. Morosky
Stefanie A. Morosky
EDElizabeth Delorme-Axford
Elizabeth Delorme-Axford
NDNaomi Dybdahl-Sissoko
Naomi Dybdahl-Sissoko
MOM. Steven Oberste
M. Steven Oberste
CCCarolyn Coyne
Carolyn Coyne
The host innate immune response to viral infections often involves the activation of parallel pattern recognition receptor (PRR) pathways that converge on the induction of type I interferons (IFNs). Several viruses have evolved sophisticated mechanisms to attenuate antiviral host signaling by directly interfering with the activation and/or downstream signaling events associated with PRR signal propagation. Here we show that the 3Cpro cysteine protease of coxsackievirus B3 (CVB3) cleaves the innate immune adaptor molecules mitochondrial antiviral signaling protein (MAVS) and Toll/IL-1 receptor domain-containing adaptor inducing interferon-beta (TRIF) as a mechanism to escape host immunity. We found that MAVS and TRIF were cleaved in CVB3-infected cells in culture. CVB3-induced cleavage of MAVS and TRIF required the cysteine protease activity of 3Cpro, occurred at specific sites and within specialized domains of each molecule, and inhibited both the type I IFN and apoptotic signaling downstream of these adaptors. 3Cpro-mediated MAVS cleavage occurred within its proline-rich region, led to its relocalization from the mitochondrial membrane, and ablated its downstream signaling. We further show that 3Cpro cleaves both the N- and C-terminal domains of TRIF and localizes with TRIF to signalosome complexes within the cytoplasm. Taken together, these data show that CVB3 has evolved a mechanism to suppress host antiviral signal propagation by directly cleaving two key adaptor molecules associated with innate immune recognition. Mammalian cells utilize a variety of defenses to protect themselves from microbial pathogens. These defenses are initiated by families of receptors termed pattern recognition receptors (PRRs) and converge on the induction of molecules that function to suppress microbial infections. PRRs respond to essential components of microorganisms that are broadly expressed within classes of pathogens. The relative non-specificity of this detection thus allows for a rapid antimicrobial response to a variety of microorganisms. Coxsackievirus B3 (CVB3), a member of the enterovirus genus, is associated with a number of diverse syndromes including meningitis, febrile illness, diabetes, and is commonly associated with virus-induced heart disease in adults and children. Despite its significant impact on human health, there are no therapeutic interventions to treat CVB3 infections. Here we show that CVB3 has evolved an effective mechanism to suppress PRR signal propagation by utilizing a virally-encoded protein, termed 3Cpro, to directly degrade molecules that function downstream of PRR signaling. By targeting these molecules, CVB3 can evade host detection and escape antiviral defenses normally induced by mammalian cells. These findings will lead to a better understanding of the mechanisms employed by CVB3 to suppress host antiviral signaling and could lead to the development of therapeutic interventions aimed at modulating CVB3 pathogenesis.